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In Reply to Helms: In the article
by Helms et al., Helms concludes that
infections with Salmonella  Typhim-
urium strains resistant to ampicillin,
chloramphenicol, streptomycin, sul-
fonamide, and tetracycline (hereafter
referred to as penta-resistant) were
associated with higher death rates than
infections with non–penta-resistant S.
Typhimurium. Helms also concluded
that infections with quinolone-resist-
ant (nalidixine-resistant) S. Typhimu-
rium were associated with higher
death rates than quinolone-susceptible
S. Typhimurium (1).
Table 2 in Helms’ article provides
information that enables close scruti-
ny of this conclusion and comparison
of the excess mortality associated
with penta-resistant, quinolone-sus-
ceptible  S.  Typhimurium with the
excess mortality of non–penta-resist-
ant S. Typhimurium (1). In this letter,
the Table is based on the original
table. However, two additional com-
parisons have been added: the p val-
ues, which are not based on the data
but are approximations based on the
parameters in the table. 
The conclusion is that only
quinolone resistance is associated
with excess mortality compared with
nonresistant isolates. Penta-resistant,
quinolone-susceptible  S.  Typhim-
urium has a risk ratio of 2.9 (1.1 to
7.9) compared to the ratio of
non–penta-resistant isolates 2.1 (1.5
to 2.9). When these figures are com-
pared, the approximate p value is
0.55, which, of course, is far from
being significant. Thus, on the basis
of the article by Helms, penta resist-
ance may not pose a greater threat to
human health than non–penta resist-
ance. However, the measured effect of
penta resistance is achieved by the
inclusion of quinolone-resistant S.
Typhimurium in the group. 
Jan Dahl*
*Danish Bacon and Meat Council,
Copenhagen, Denmark
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In Reply to Dahl: The emergence
and spread of multidrug-resistant
Salmonella enterica  serovar
Typhimurium DT104 (MDR DT104)
contributed to an international
increase in antimicrobial drug resist-
ance in S. Typhimurium in the late
1990s (1,2). This type of Salmonella
is usually resistant to five drugs:
ampicillin, chloramphenicol, strepto-
mycin, sulfonamides, and tetracycline
(R-type ACSSuT) and easily acquires
resistance to other drugs, including
quinolones, trimethoprim, and amino-
glycosides (1,3–5). To determine
death rates after infection with MDR
DT104 or closely related strains, we
identified patients who were infected
with strains at least resistant to
ACSSuT (6). Analysis limited to
strains that were only R-type ACSSuT
would have given a misleading result
since MDR DT104 often, as men-
tioned, develops additional resistance
to other classes of antimicrobial drugs
in addition to the ACSSuT-complex.
This fact needs to be taken into
account in any attempt to quantify the
overall public health impact of MDR
DT104 and related strains.
We found, in our matched cohort
study (6), that 283 patients infected
with strains resistant to at least
ACSSuT were 4.8 times more likely
to die than the general Danish popula-
tion, compared with 2.3 for 953
patients infected with pansusceptible
strains. This difference in death rates
ocurred mainly because 40 of the 283
strains had R-type ACSSuTNx (i.e.,
additional resistance to nalidixic
acid), and infection with this strain in
particular is associated with a high
death rate (relative mortality 13.1). As
Dahl suggests, infection with R-type
ACSSuT (Nx susceptible) was not
Table. Table showing additional comparisons (1)
a 
Resistant  Susceptible 
 
Deaths/ 
cases  RR
b  (95% CI) 
Deaths/ 
cases  RR
b (95 % CI)  p value 
Penta with and 
without quinolone 
12/283  4.8 (2.2 to 10.5)  47/1,764  2.1 (1.5 to 2.9)  0.06 
Penta with 
quinolone 
5/40  13.1 (3.3 to 51.9)  47/1,764  2.1 (1.5 to 2.9)
c  0.01
d 
Penta without 
quinolone 
7/243  2.9 (1.1 to 7.9)  47/1764  2.1 (1.5 to 2.9)
c  0.55c
d 
aRR, relative risk; CI, confidence interval. 
bAdjusted for coexisting conditions.
 
cCompared to the non-penta group. 
dApproximations based on the parameters from the table. 